JCS 2018 guideline on diagnosis of chronic coronary heart diseases

M Yamagishi, N Tamaki, T Akasaka, T Ikeda… - Circulation …, 2021 - jstage.jst.go.jp
Objectives”, explains how to select and use various test methods for evaluating disease
states, the prognosis, and the effects of treatment. References to the literature published …

Reperfused vs. nonreperfused myocardial infarction: when to use which model

ML Lindsey, LE de Castro Brás… - American Journal …, 2021 - journals.physiology.org
There is a lack of understanding in the cardiac remodeling field regarding the use of
nonreperfused myocardial infarction (MI) and reperfused MI in animal models of MI. This …

Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies

F Hofer, N Kazem, A Hammer… - European Heart …, 2021 - academic.oup.com
Aims While the prognosis of patients presenting with de novo atrial fibrillation (AF) during the
acute phase of myocardial infarction has been controversially discussed, it seems intuitive …

Risk of arrhythmias after myocardial infarction in patients with left ventricular systolic dysfunction according to mode of revascularization: a Cardiac Arrhythmias and …

AF Thomsen, PK Jacobsen, L Køber… - EP …, 2021 - academic.oup.com
Abstract Aims The Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction
(CARISMA) study was an observational trial including 312 patients with acute myocardial …

[PDF][PDF] Anna F. Thomsen*, Peter Karl Jacobsen, Lars Køber, Rikke Moerch Joergensen 2, Heikki V. Huikuri 3, Poul Erik Bloch Thomsen 4, Uffe G. Jacobsen 5, and

C Jøns - Europace, 2021 - researchgate.net
Aims The Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA)
study was an observational trial including 312 patients with acute myocardial infarction (MI) …